Angiopoietin-Related Growth Factor Suppresses Gluconeogenesis through the Akt/Forkhead Box Class O1-Dependent Pathway in Hepatocytes
Open Access
- 5 September 2007
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Journal of Pharmacology and Experimental Therapeutics
- Vol. 323 (3), 787-793
- https://doi.org/10.1124/jpet.107.127530
Abstract
Angiopoietin-related growth factor (AGF; or Angptl6) is a liver-derived, circulating factor and is considered to be a regulator of metabolic homeostasis. AGF is capable of counteracting both obesity and obesity-related insulin resistance. However, the target tissues and the molecular mechanisms underlying the antiobesity and antidiabetic actions of AGF have not been completely defined. Using rat hepatoma H4IIEc3 cells or primary hepatocytes, we demonstrate that AGF suppresses glucose production in a concentration-dependent manner through reduced expression of a key gluconeogenic enzyme, glucose-6-phosphatase (G6Pase), at both transcriptional and translational levels. The action of AGF on glucose production was inhibited by pretreatment of the cells with LY294002 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one], a phosphoinositide 3-kinase (PI3K) inhibitor, and Akt (protein kinase B) inhibitors. AGF increased the phosphorylation of Akt and its substrates, glycogen synthase kinase 3β and forkhead box class O1 (FoxO1), a key transcription factor for G6Pase expression. Furthermore, an immunohistochemical approach with anti-FoxO1 antibody demonstrated that AGF stimulation promoted translocation of FoxO1 from the nucleus to the cytoplasm in the cells. These results suggest that in hepatocytes, AGF suppresses gluconeogenesis via reduced transcriptional activity of FoxO1 resulting from the activation of PI3K/Akt signaling cascades.Keywords
This publication has 29 references indexed in Scilit:
- Angiopoietin-related growth factor (AGF) supports adhesion, spreading, and migration of keratinocytes, fibroblasts, and endothelial cells through interaction with RGD-binding integrinsBiochemical and Biophysical Research Communications, 2006
- Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularizationJCI Insight, 2005
- Ageing and metabolism: drug discovery opportunitiesNature Reviews Drug Discovery, 2005
- FoxO proteins in insulin action and metabolismTrends in Endocrinology & Metabolism, 2005
- Angiopoietin-related growth factor (AGF) promotes angiogenesisBlood, 2004
- Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interactionNature, 2003
- Differential Regulation of Endogenous Glucose-6-Phosphatase and Phosphoenolpyruvate Carboxykinase Gene Expression by the Forkhead Transcription Factor FKHR in H4IIE-Hepatoma CellsBiochemical and Biophysical Research Communications, 2001
- Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targettingBiochemical Journal, 2001
- Regulation of Glucose-6-phosphatase Gene Expression by Protein Kinase Bα and the Forkhead Transcription Factor FKHRPublished by Elsevier BV ,2000
- Dominant Negative Forms of Akt (Protein Kinase B) and Atypical Protein Kinase Cλ Do Not Prevent Insulin Inhibition of Phosphoenolpyruvate Carboxykinase Gene TranscriptionPublished by Elsevier BV ,1999